Eversept Partners’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Sell |
1,695,762
-2,201,079
| -56% | -$2.71M | 0.19% | 51 |
|
|
2025
Q1 | $4.29M | Sell |
3,896,841
-1,081,617
| -22% | -$1.19M | 0.44% | 33 |
|
|
2024
Q4 | $4.5M | Hold |
4,978,458
| – | – | 0.4% | 41 |
|
|
2024
Q3 | $4.91M | Sell |
4,978,458
-505,690
| -9% | -$499K | 0.34% | 37 |
|
|
2024
Q2 | $4.94M | Sell |
5,484,148
-510,324
| -9% | -$460K | 0.34% | 41 |
|
|
2024
Q1 | $7.07M | Sell |
5,994,472
-438,243
| -7% | -$517K | 0.47% | 39 |
|
|
2023
Q4 | $5.87M | Buy |
6,432,715
+2,004,858
| +45% | +$1.83M | 0.52% | 33 |
|
|
2023
Q3 | $3.69M | Buy |
4,427,857
+3,678,160
| +491% | +$3.06M | 0.31% | 44 |
|
|
2023
Q2 | $900K | Sell |
749,697
-602,368
| -45% | -$723K | 0.08% | 60 |
|
|
2023
Q1 | $1.7M | Buy |
1,352,065
+1,197,853
| +777% | +$1.51M | 0.12% | 49 |
|
|
2022
Q4 | $335K | Sell |
154,212
-394,219
| -72% | -$855K | 0.03% | 57 |
|
|
2022
Q3 | $6.57M | Buy |
548,431
+80,128
| +17% | +$960K | 0.57% | 30 |
|
|
2022
Q2 | $3.92M | Buy |
468,303
+93,580
| +25% | +$783K | 0.28% | 43 |
|
|
2022
Q1 | $3.25M | Buy |
374,723
+334,813
| +839% | +$2.91M | 0.25% | 47 |
|
|
2021
Q4 | $451K | Sell |
39,910
-110,000
| -73% | -$1.24M | 0.03% | 85 |
|
|
2021
Q3 | $1.88M | Buy |
+149,910
| New | +$1.88M | 0.13% | 66 |
|